Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Receivables (2023 - 2025)

Ardent Health (ARDT) has 3 years of Receivables data on record, last reported at $760.3 million in Q3 2025.

  • For Q3 2025, Receivables rose 2.06% year-over-year to $760.3 million; the TTM value through Sep 2025 reached $760.3 million, up 2.06%, while the annual FY2024 figure was $785.6 million, 2.99% down from the prior year.
  • Receivables reached $760.3 million in Q3 2025 per ARDT's latest filing, down from $821.6 million in the prior quarter.
  • Across five years, Receivables topped out at $821.6 million in Q2 2025 and bottomed at $744.9 million in Q3 2024.
  • Average Receivables over 3 years is $784.9 million, with a median of $785.6 million recorded in 2024.
  • Peak YoY movement for Receivables: decreased 2.99% in 2024, then rose 9.18% in 2025.
  • A 3-year view of Receivables shows it stood at $809.9 million in 2023, then decreased by 2.99% to $785.6 million in 2024, then decreased by 3.22% to $760.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $760.3 million in Q3 2025, $821.6 million in Q2 2025, and $819.1 million in Q1 2025.